Agenus buying Xoma pilot plant in one of three antibody-focused deals
Agenus has bolstered its capabilities through a string of deals including the acquisition of an antibody GMP pilot facility from fellow biotech Xoma.
Archives for November 13, 2015
Greater education efforts needed to aid biosimilars in US, say developers
Education is vital for biosimilar success in the US market, according to an industry advocacy group which is preparing to launch a programme for patients and healthcare providers.